Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 2021
Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG "ANITA"
Patrick Schöffski, Maud Toulmonde, Anna Estival, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2019
Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)
Roberta Sanfilippo, Robin L Jones, Jean-Yves Blay, et al.
British Journal of Cancer
|
October 8, 2024
Role of <sup>18</sup>F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?
Nina Jehanno, Nadège Corradini, Nathalie Gaspar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 17, 2024
Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETO
Jean-Yves Blay, Nicolas Penel, Maud Toulmonde, et al.
Cancer Medicine
|
December 20, 2022
Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma group
Mehdi Brahmi, Nathalie Gaspar, Justine Gantzer, et al.
Cancer Research Communications
|
June 11, 2026
Predicting clinical sensitivities of PDGFRA exon 18 mutations to imatinib and avapritinib to optimize gastrointestinal stromal tumor treatment
Homma M Khosroyani, Alina Teuber, Ajia Town, et al.
Cancers
|
September 9, 2023
Evolution of Patterns of Care and Outcomes in the Real-Life Setting for Patients with Metastatic GIST Treated in Three French Expert Centers over Three Decades
Maud Toulmonde, Derek Dinart, Mehdi Brahmi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2021
Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study
Yoon-Koo Kang, Suzanne George, Robin L Jones, et al.
International Journal of Cancer
|
July 24, 2025
Metastatic chondrosarcoma, patterns of care, and outcomes of patients in a real-life national setting over a decade
Coline Ducrot, Derek Dinart, Mathilde Reich, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2026
Natural history and treatment sensitivity of alveolar soft part sarcoma: A national multicenter analysis from the French sarcoma group
Eva Kalfala, Alexandra Meurgey, Clémence Hénon, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
European Journal of Cancer (Oxford, England : 1990)
|
June 1, 2021
Randomised phase 2 study comparing the efficacy and safety of the oral tyrosine kinase inhibitor nintedanib with single agent ifosfamide in patients with advanced, inoperable, metastatic soft tissue sarcoma after failure of first-line chemotherapy: EORTC-1506-STBSG "ANITA"
Patrick Schöffski, Maud Toulmonde, Anna Estival, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 21, 2019
Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)
Roberta Sanfilippo, Robin L Jones, Jean-Yves Blay, et al.
British Journal of Cancer
|
October 8, 2024
Role of <sup>18</sup>F-FDG-PET/CT in the initial staging of very high-risk Ewing Sarcoma in a prospective multicentric Phase II Study: Is there still a place for bone marrow sampling?
Nina Jehanno, Nadège Corradini, Nathalie Gaspar, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 17, 2024
Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETO
Jean-Yves Blay, Nicolas Penel, Maud Toulmonde, et al.
Cancer Medicine
|
December 20, 2022
Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma group
Mehdi Brahmi, Nathalie Gaspar, Justine Gantzer, et al.
Cancer Research Communications
|
June 11, 2026
Predicting clinical sensitivities of PDGFRA exon 18 mutations to imatinib and avapritinib to optimize gastrointestinal stromal tumor treatment
Homma M Khosroyani, Alina Teuber, Ajia Town, et al.
Cancers
|
September 9, 2023
Evolution of Patterns of Care and Outcomes in the Real-Life Setting for Patients with Metastatic GIST Treated in Three French Expert Centers over Three Decades
Maud Toulmonde, Derek Dinart, Mehdi Brahmi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2021
Avapritinib Versus Regorafenib in Locally Advanced Unresectable or Metastatic GI Stromal Tumor: A Randomized, Open-Label Phase III Study
Yoon-Koo Kang, Suzanne George, Robin L Jones, et al.
International Journal of Cancer
|
July 24, 2025
Metastatic chondrosarcoma, patterns of care, and outcomes of patients in a real-life national setting over a decade
Coline Ducrot, Derek Dinart, Mathilde Reich, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2026
Natural history and treatment sensitivity of alveolar soft part sarcoma: A national multicenter analysis from the French sarcoma group
Eva Kalfala, Alexandra Meurgey, Clémence Hénon, et al.
Page
of 8